Life-threatening Mast Cell Activation and Anaphylaxis in Mast Cell Leukemia and the Role of Omalizumab

被引：0

作者：

Hammond, T. C. ^{[1
]}

Emeruwa, I. ^{[1
]}

Swain, S. R. ^{[2
]}

Larson, S. M. ^{[3
]}

Castells, M. C. ^{[4
]}

机构：

[1] UCLA, Pulmonary Crit Care Sleep Med, Santa Monica, CA USA

[2] UCLA, Allergy & Immunol, Santa Monica, CA USA

[3] UCLA, Hematol Oncol, Los Angeles, CA USA

[4] Brigham & Womens Hosp, Allergy & Immunol, Boston, MA USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A5294

引用

页数：2

共 50 条

[1] Mast cell activation syndrome presenting as a life-threatening situation
Pereira, Ana Isabel
Fernandes, Diana
Mueller, Sofia
ANESTHESIA AND ANALGESIA, 2021, 133 (3S_SUPPL): : 256 - 257
[2] IDIOPATHIC ANAPHYLAXIS, MAST CELL ACTIVATION SYNDROME CONTROLLED WITH OMALIZUMAB
Chen, M.
Kim, A.
Christiansen, S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S30 - S31
[3] Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab
Bell, Matthew C.
Jackson, Daniel J.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (05) : 383 - 384
[4] Omalizumab For a Case Of Monoclonal Mast Cell Activation Syndrome With Recurrent Anaphylaxis
Jagdis, Amanda
Vadas, Peter
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB27 - AB27
[5] Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disorders
Valent, P.
CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (07): : 914 - 920
[6] OMALIZUMAB IN TREATMENT OF MAST CELL ACTIVATION SYNDROME
Brown, R.
Yao, L.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S86 - S87
[7] Successful treatment of refractory anaphylaxis using omalizumab in monoclonal mast cell activation syndrome
O'Keefe, A.
ALLERGY, 2018, 73 : 466 - 466
[8] ROLE OF MAST CELL IN ANAPHYLAXIS IN MOUSE
EINBINDER, JM
NELSON, CT
WALZER, RA
JOURNAL OF IMMUNOLOGY, 1964, 93 (01): : 165 - &
[9] Mast Cell Activation Syndromes Presenting as Anaphylaxis
Akin, Cem
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2015, 35 (02) : 277 - +
[10] Omalizumab effectively prevents recurrent refractory anaphylaxis in patient with monoclonal mast cell activation syndrome
Jagdis, Amanda
Vadas, Peter
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (01) : 115 - 116

← 1 2 3 4 5 →